SteadyMed Therapeutics
SteadyMed aspires to redefine the parenteral therapeutics experience for patients dependent upon large doses of intravenous and subcutaneous medications.
Launch date
Employees
Market cap
-
Enterprise valuation
€196m (Public information from Apr 2018)
Rehovot Center District (HQ)
Authorizing premium user...